ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Session » (1913–1944) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Date: Tuesday, November 14, 2023

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2023

9:00AM-11:00AM
Abstract Number: 1920
A Phase Ib/II Randomized, Double-blind, Placebo-controlled Study of Novel anti-IL-17A Monoclonal Antibody JS005 in Patients with Moderate to Severe Psoriasis
9:00AM-11:00AM
Abstract Number: 1940
A Single-center, Observational, Retrospective, Case Control Study of Rituximab for the Treatment of Interstitial Pneumonia Associated with Autoimmune Features
9:00AM-11:00AM
Abstract Number: 1929
Anakinra Treatment in Idiopathic Recurrent Pericarditis: A Single-center Experience
9:00AM-11:00AM
Abstract Number: 1933
Analysis of IgG4-Related Disease in a Diverse Long Island Population: Insights from the Rheumatology Clinic
9:00AM-11:00AM
Abstract Number: 1931
Anti-Ku Antibodies: A Case Series
9:00AM-11:00AM
Abstract Number: 1919
Arthroplasty Outcomes in Immune Checkpoint Inhibitor-Treated Patients: A Single Center Series
9:00AM-11:00AM
Abstract Number: 1930
Blue Digit Syndrome as the Initial Presentation of Various Diseases: A Case Series
9:00AM-11:00AM
Abstract Number: 1944
Characterization of Interstitial Pneumonia with Autoimmune Features (IPAF) in a National Referral Centre
9:00AM-11:00AM
Abstract Number: 1916
Clinical Features of the Patients with NLRP1 Gene Variants and a Systemic Autoinflammatory Phenotype
9:00AM-11:00AM
Abstract Number: 1921
Clinical Spectrum of VEXAS Syndrome in a Rheumatology Department
9:00AM-11:00AM
Abstract Number: 1938
Cranial Nerve Manifestations in Sarcoidosis Associated with Lymphoma, Non-facial Paralysis, and Other Neurologic Disorders
9:00AM-11:00AM
Abstract Number: 1937
Efficacy of Different Treatment Approaches for Cardiac Sarcoidosis
9:00AM-11:00AM
Abstract Number: 1936
Higher Rates of Disease Control During the Coronavirus Pandemic in Pediatric Patients with Autoinflammatory Periodic Diseases on Canakinumab Treatment – Interim Data from the RELIANCE Registry
9:00AM-11:00AM
Abstract Number: 1941
Identification of VEXAS Syndrome in Mexican Patients with Inflammatory and Hematologic Manifestations
9:00AM-11:00AM
Abstract Number: 1943
IgG4-related Disease: 2010-2022 Case Review and Comparative Evaluation of Diagnostic Criteria
9:00AM-11:00AM
Abstract Number: 1924
Impact of the COVID-19 Pandemic on Clinical and Psychosocial Features of Patients with UCTD
9:00AM-11:00AM
Abstract Number: 1925
Importance of the Patient Pain Experience in Disease Activity Assessment in the Adult SAPHO and Chronic Nonbacterial Osteomyelitis Study
9:00AM-11:00AM
Abstract Number: 1914
Intravenous Immunoglobulins in the Treatment of Idiopathic Inflammatory Myopathies in a Region of Northern Spain: Analysis by Subtypes
9:00AM-11:00AM
Abstract Number: 1927
Manifestations, Management and Outcomes of Interstitial Lung Disease Associated with Anti-synthetase Syndrome: A Systematic Literature Review
9:00AM-11:00AM
Abstract Number: 1918
Nationwide Analysis of Predictors of Sarcoid Inpatient Mortality
9:00AM-11:00AM
Abstract Number: 1913
Neurosarcoidosis Disease Epidemiology. University Hospital in Northern Spain 1999-2019
9:00AM-11:00AM
Abstract Number: 1934
Pooled Safety Analysis from the VOLTAIRE Trials in Patients with Rheumatoid Arthritis, Crohn’s Disease, and Chronic Plaque Psoriasis
9:00AM-11:00AM
Abstract Number: 1935
Pre-exposure Prophylaxis with Tixegvimab/cilgavimab Is Effective in Limiting the Risk and Severity of COVID-19 in Patients with Auto Immune or Inflammatory Diseases at Increased Risk of Severe COVID-19
9:00AM-11:00AM
Abstract Number: 1923
Prevalence and Patterns of Comorbidities in Different Rheumatic Diseases: A Study from Tertiary Healthcare Centre
9:00AM-11:00AM
Abstract Number: 1942
Prevalence and Screening Strategy for Latent Tuberculosis Infection in Patients with Rheumatic Immune-Mediated Diseases
9:00AM-11:00AM
Abstract Number: 1917
Reducing Inadvertent Antifilarial Antibody Testing at an Academic Medical Center: A Quality Improvement Project
9:00AM-11:00AM
Abstract Number: 1928
Response to Sars-Cov2 Vaccination in Rheumatic and Neurological Patients Treated with Different Immunosuppressive Therapies
9:00AM-11:00AM
Abstract Number: 1915
Scleritis and Development of Autoimmune Disease: A Case Series
9:00AM-11:00AM
Abstract Number: 1939
Sinonasal Sarcoidosis Associated with Chronic Pulmonary Disease, Deficiency Anemias, and Obesity
9:00AM-11:00AM
Abstract Number: 1932
The Association Between Initial Ferritin and Complications from Adults Onset Stills Disease and Intensive Care Unit Admission
9:00AM-11:00AM
Abstract Number: 1926
Use of 18F-FDG PET in Assessing Response to Treatment in Adults with Pulmonary Sarcoidosis: A Systematic Literature Review
9:00AM-11:00AM
Abstract Number: 1922
Use of Plasma with High Titer Neutralizing Autoantibodies to Type I Interferons in Patients with Severe Refractory Flare-up of Hidradenitis Suppurativa as Novel Passive Immunotherapy Approach: Trial Protocol

« View all sessions from this meeting

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology